was a significant drop of outbreaks and case incidences. The accrued experience evidenced the need of an information system available at National level providing efficient timely communications and data sharing for appropriate actions. A WEBGIS developed by the Italian EIA National Reference Centre (NRCEIA) was tested in 2015 at Regional level (Latium) to: ensure real time tracking of EIA case location; trigger immediate alerts on new cases and outbreaks; allow risk evaluation and management of equid movements; provide practical tools for Veterinary Officers for surveillance, control or emergency actions in infected areas. The WEBGIS was also specifically oriented as a practical instrument for outbreak management. The Geo-portal was developed using open-source geographical layers (Base map aerials, topography, streets and municipalities borders) and programming softwares with the geodatabase automatically fed using official sources of structured data relative to farm registration and location, confirmed cases and officially notified outbreaks through dedicated web-services, providing an interactive, unified SOAP interface display to users with daily updating. By accessing to CRAIE-WEBGIS webpage (http://195.45.99.77/craie/), the Local, Regional and National Veterinary Authorities can generate and display the list and location of the confirmed cases and the notified outbreaks. Details on outbreak status (i.e. from suspected to confirmed or to extinguished, species and number of individuals involved) are daily tracked and available. Controlling the retrospective geodatabase, it is possible to discriminate incident from recurrent cases and outbreaks as also activate the display of the areas at risk around the active outbreaks, allowing the automatic listing of all the farms registered within a defined surveillance buffer/area, where targeted serological and syndromic surveillance must be put in place. Further to the dynamic tools, the CRAIE-WEBGIS also releases periodic static reports (lists and maps) relative to outbreak characteristics and location, allowing a timely supervision of the actions undertaken and a preliminary evaluation of the epidemiological trends. The CRAIE-WEBGIS experience in Latium contributed to reduce uncertainty, provide timely and effective actions, raising the biosecurity level of the equid population. Its extension at a national level will support the country surveillance, data collection and outbreak tracking, allowing the derived epidemiological data to be used for risk assessment and management and timely evidence-based interventions.
was a significant drop of outbreaks and case incidences. The accrued experience evidenced the need of an information system available at National level providing efficient timely communications and data sharing for appropriate actions. A WEBGIS developed by the Italian EIA National Reference Centre (NRCEIA) was tested in 2015 at Regional level (Latium) to: ensure real time tracking of EIA case location; trigger immediate alerts on new cases and outbreaks; allow risk evaluation and management of equid movements; provide practical tools for Veterinary Officers for surveillance, control or emergency actions in infected areas. The WEBGIS was also specifically oriented as a practical instrument for outbreak management. The Geo-portal was developed using open-source geographical layers (Base map aerials, topography, streets and municipalities borders) and programming softwares with the geodatabase automatically fed using official sources of structured data relative to farm registration and location, confirmed cases and officially notified outbreaks through dedicated web-services, providing an interactive, unified SOAP interface display to users with daily updating. By accessing to .77/craie/), the Local, Regional and National Veterinary Authorities can generate and display the list and location of the confirmed cases and the notified outbreaks. Details on outbreak status (i.e. from suspected to confirmed or to extinguished, species and number of individuals involved) are daily tracked and available. Controlling the retrospective geodatabase, it is possible to discriminate incident from recurrent cases and outbreaks as also activate the display of the areas at risk around the active outbreaks, allowing the automatic listing of all the farms registered within a defined surveillance buffer/area, where targeted serological and syndromic surveillance must be put in place. Further to the dynamic tools, the CRAIE-WEBGIS also releases periodic static reports (lists and maps) relative to outbreak characteristics and location, allowing a timely supervision of the actions undertaken and a preliminary evaluation of the epidemiological trends. The CRAIE-WEBGIS experience in Latium contributed to reduce uncertainty, provide timely and effective actions, raising the biosecurity level of the equid population. Its extension at a national level will support the country surveillance, data collection and outbreak tracking, allowing the derived epidemiological data to be used for risk assessment and management and timely evidence-based interventions. As in other mammals, horses can be affected by several fungal infections. However, only a small number of these are known to cause clinical disease and death. Multiple species of fungus are ubiquitous in the environment, and thus horses can acquire the fungal spores by inhalation, ingestion or contact (skin and mucosa). In addition, there is a predisposition for disease development related with the environmental conditions and the host's immune conditions. The aim of this report is to describe the features and clinical findings in a series of equine mortalities occurred in a Thoroughbred and Quarter Mile horse breeding farm located in Cañuelas, Buenos Aires Province, Argentina. The affected population consisted of 20 nursing foals (between 3 to 6 months of age). They were allowed to graze freely on natural pasture, without supplementation of dry (hay) or other commercial equine feed. Due to the excessive rainfall, the animals were frequently moved over different paddocks for food access. During February-April 2014, 7 foals and 1 mare showed hyperthermia, depression, edema, profuse diarrhea, colic, serous nasal secretion and mucous membrane congestion. These clinical signs were followed by the development of ulcerative lesions with posterior necrosis of nasal septum mucosa. Even though all the affected animals received analgesic, antipyretic, antidiarrheal and different antibiotics treatment, no improvement was obtained. The course of the disease was variable between 2 and 45 days. Ultrasonography revealed the presence of Rhodococcus equi (R. equi)-like lesions (abscesses) in the lungs in 6 out of the 7 affected foals. Nasal turbinates swabs (NS), tracheal washes (TW), whole blood to obtain peripheral blood mononuclear cells (PMBC) and serum samples were collected for microbiological studies (virology, bacteriology and mycology). Exhaustive necropsy, tissue samples collection and histopathology and microbiology studies were performed. No virus was detected in NS or PBMC. No antibodies against Burkhordelia mallei (Glanders) were identified. At necropsy, the most consistent lesions were ulcers and necrosis of nasal septum; similar lesions but of lesser extent were also found in the tongue, palate and along the gastrointestinal tract. Lesions compatibles with those induced by R. equi were not observed in the lung. Histopathology revealed severe acute multifocal necrotizing interstitial pneumonia; severe chronic multifocal necrotizing rhinitis with vasculitis and intralesional fungal hyphae in nasal turbinates, and mild to severe suppurative inflammation with marked lymphoid depletion in colon. The fungi in the nasal turbinates were morphologically consistent with Zygomycetes (Mucor, Basidiobolus, Conidiobolus) or Oomycetes (Pythiumsp). Unfortunately, the etiology of the disease and death of these horses could not be determined; the presence of fungus-like microorganisms in the lesions could be a result of secondary infection due to intestinal injury. Anthrax is a highly pathogenic zoonotic disease caused by Bacillus anthracis, a Gram positive spore-forming bacillus. Although it primarily affects herbivores, other mammals, including humans, can be affected. Animals may have at least three clinical presentations, hyperacute, acute, and subacute or chronic; horses almost always develop the acute form, generally manifesting throatlatch swelling, fever, dispnoea, rapid onset of septicemia, disseminated intravascular coagulation and shock. Bleeding from natural orifices is common in most species. The importance in public health lies in its zoonotic potential. Three forms of presentation have been described in humans: cutaneous, respiratory and digestive, depending on the route of exposure. Lethality in humans is extremely high without rapid detection and treatment.
In December 2013, an adult crossbred work horse, belonging to persons of extremely limited resources, presented at the Universidad Austral de Chile's Veterinary Hospital due to sudden decay. No other sick horses were reported at the farm of origin; there was no vaccination history. Clinical examination revealed severe depression, generalized muscle twitching, severe tachycardia and tachypnea, hypothermia, hypovolemia, severe edema of the glottis, and hypotonia of the anal sphincter. During the initial assessment, the patient developed bilateral epistaxis. Faced with signs of respiratory obstruction (due to retropharyngeal edema and lymphadenopathy) and severe coagulopathy, the animal was euthanized. Necropsy revealed blood incoagulability, multiple organ congestion and retromandibular edema. Parotid lymph node samples were taken, and anthrax was confirmed by microbiological culture of Bacillus anthracis within 72 hours of death. With this diagnosis, the competent national health service was immediately notified for coordination of post-exposure interventions. Four people had been directly exposed to the animal (two owners and four university employees; two veterinarians were exposed to spore inhalation during necropsy), and 7 others were determined to have been on the premises. The health service provided health monitoring guidelines and antibiotic prophylaxis (ciprofloxacin 500 mg twice daily) for a period of 60 days for all exposed owners and personnel. All directly exposed individuals' clothing and residual biological material was incinerated. The equine veterinary hospital was emptied of all animals (none of which were exposed to the patient), and contaminated premises were thrice disinfected with quaternary ammonia and glutaraldehyde. There were no manifestations of disease in the people involved, and no ulterior equine cases. Although anthrax is endemic in Chile, with 37 human cases reported between 2000-2009, animal vaccination is rare and no equine cases have been described since 1990 (Araya et al, 1990) . This case is noteworthy on account of the rare occurrence of the disease, and because rapid cooperation of veterinarians and the national health service permitted continued monitoring and prophylactic treatment of the university personnel and of the poorly educated owners of the horse, thereby avoiding human cases. Thus, urgent mandatory reporting of suspected cases should be emphasized. Figure 1 ) is a frequently fatal neurodegenerative disease affecting grazing equids, predominantly in northern European and South American countries. It is hypothesised that EGS represents a toxico-infectious form of botulism, where a combination of risk factors triggers in-vivo production of Clostridium botulinum type C toxins by bacteria present within the gastrointestinal tract. Several previous studies have reported a protective effect of natural immunity to C. botulinum type C. To date, no vaccine is available for EGS prevention. This study aimed to determine safety and immunogenicity of a modern C. botulinum type C vaccine intended for EGS prevention, in the target species. An experimental randomised, triple-blinded, placebocontrolled safety study of a C. botulinum type C bacterin-toxoid vaccine was undertaken in 15 foals (aged 10-14 weeks). Foals were randomly assigned to one of two groups at a 1:2 ratio, and received either the test vaccine (n¼10) or placebo (sterile saline) (n¼5), with four intramuscular injections administered at 21 days intervals. All personnel performing animal care, clinical examinations and laboratory analyses were unaware of the foals' vaccination status. Health assessments were performed daily from day -2 until day 70, and clinical assessments were performed daily on the day of each injection and six days subsequently. To evaluate vaccine immunogenicity, serum samples were obtained on days 0, 14, 21, 35, 42, 56, 63, 77 , and 91 and analysed using an indirect C. botulinum type C ELISA. Analysis of variance and Student's t-test or Wilcoxon signed rank tests were used to conduct intra-and inter-group comparisons, respectively. No immediate post-vaccination adverse events or systemic adverse reactions were observed during the study. Local site reaction was limited to one vaccinated foal. On day 0, there was no difference in mean ELISA optical density (OD) between treatment groups (p¼0.73). There was a significant increase in C. botulinum type C antibody levels within the vaccinated group, with pre-V1<post-V2<post-V3, and all vaccinated animals had seroconverted following V3 (Figure 2) . Antibody levels remained low in the placebo-treated control group. This study demonstrates the first evidence of safety and immunogenicity of a C. botulinum type C equine vaccine, which warrants further evaluation as a candidate vaccine for EGS prevention. The safety study was funded by Neogen Corporation. 
